February 19, 2026 · Form 4 insider transaction
Busch Matthew C. sold 1,000 shares of Amgen Inc. at $375.79 per share, a transaction worth $375.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.